Bai Lu

Title: Bai Lu - Innovator in TrkB Agonist Antibodies

Introduction

Bai Lu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of TrkB agonist antibodies. With a total of 2 patents, his work focuses on innovative methods for treating conditions associated with TrkB.

Latest Patents

Bai Lu's latest patents include the development of anti-TrkB agonist antibodies that bind to the D1 domain of TrkB. This invention provides an isolated TrkB agonist antibody capable of activating TrkB, which is crucial for various biological processes. The extracellular domains of TrkB include D1, D2, D3, D4, D5, and the juxtamembrane domain. The methods outlined in this patent aim to treat or reduce the risk of conditions such as cell differentiation, synaptic development, neural injury repair, and neurite branching. Another significant patent involves anti-TrkB agonist antibodies binding to the D5 domain of TrkB, which promotes neuronal survival in cases of motor neuron injury, stroke, or glaucoma. This patent also emphasizes the importance of TrkB activation in similar therapeutic contexts.

Career Highlights

Bai Lu has worked at Tsinghua University, where he has been involved in cutting-edge research and development. His academic background and professional experience have positioned him as a key figure in the field of neuroscience and biotechnology.

Collaborations

Bai Lu has collaborated with notable individuals such as Wei Guo and Hongyang Yao, contributing to the advancement of research in his area of expertise.

Conclusion

Bai Lu's innovative work in the development of TrkB agonist antibodies showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various neurological conditions.